Arax Advisory Partners’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$271K Sell
3,317
-3,218
-49% -$263K 0.01% 556
2025
Q1
$454K Sell
6,535
-1,389
-18% -$96.5K 0.03% 332
2024
Q4
$682K Buy
7,924
+4,315
+120% +$371K 0.04% 230
2024
Q3
$430K Sell
3,609
-28
-0.8% -$3.33K 0.04% 224
2024
Q2
$519K Sell
3,637
-158
-4% -$22.6K 0.05% 183
2024
Q1
$487K Sell
3,795
-183
-5% -$23.5K 0.05% 180
2023
Q4
$411K Buy
3,978
+1,689
+74% +$175K 0.05% 186
2023
Q3
$208K Buy
2,289
+153
+7% +$13.9K 0.03% 252
2023
Q2
$173K Buy
2,136
+16
+0.8% +$1.29K 0.02% 264
2023
Q1
$169K Buy
2,120
+186
+10% +$14.8K 0.02% 263
2022
Q4
$131K Sell
1,934
-36
-2% -$2.44K 0.02% 290
2022
Q3
$98K Buy
1,970
+176
+10% +$8.76K 0.02% 314
2022
Q2
$100K Buy
1,794
+712
+66% +$39.7K 0.02% 315
2022
Q1
$60K Buy
1,082
+996
+1,158% +$55.2K 0.01% 424
2021
Q4
$5K Buy
86
+70
+438% +$4.07K ﹤0.01% 769
2021
Q3
$1K Buy
+16
New +$1K ﹤0.01% 922
2020
Q4
$8K Hold
232
﹤0.01% 595
2020
Q3
$8K Buy
232
+2
+0.9% +$69 ﹤0.01% 566
2020
Q2
$8K Buy
230
+2
+0.9% +$70 ﹤0.01% 560
2020
Q1
$7K Hold
228
﹤0.01% 553
2019
Q4
$7K Hold
228
﹤0.01% 497
2019
Q3
$6K Hold
228
﹤0.01% 505
2019
Q2
$6K Buy
+228
New +$6K ﹤0.01% 507
2018
Q4
$5K Sell
224
-154
-41% -$3.44K ﹤0.01% 490
2018
Q3
$9K Sell
378
-2,328
-86% -$55.4K ﹤0.01% 478
2018
Q2
$62K Sell
2,706
-88
-3% -$2.02K 0.03% 203
2018
Q1
$68K Sell
2,794
-7,300
-72% -$178K 0.04% 174
2017
Q4
$270K Buy
10,094
+40
+0.4% +$1.07K 0.12% 73
2017
Q3
$242K Sell
10,054
-326
-3% -$7.85K 0.12% 75
2017
Q2
$223K Buy
10,380
+618
+6% +$13.3K 0.11% 84
2017
Q1
$167K Buy
9,762
+2,814
+41% +$48.1K 0.08% 86
2016
Q4
$125K Buy
+6,948
New +$125K 0.06% 96